Pricing Log in Create free account

CERo Therapeutics Holdings, Inc. (CERO) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)

CERo Therapeutics Holdings, Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Scinai Immunotherapeutics Ltd. Sponsored ADR is the larger, with a market value of $640.0K against $140.0K — 4.6× the size. CERo Therapeutics Holdings, Inc. trades at the lower P/E: 0.0× against 0.0×. Across the 9 metrics below, CERo Therapeutics Holdings, Inc. leads on 6 and Scinai Immunotherapeutics Ltd. Sponsored ADR on 3.

Valuation

Metric CERO SCNI Biotechnology median
P/E 0.00 0.01 8.50
P/S n/m n/m 9.71
P/B n/m 0.05 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.28 0.64
EV/Sales n/m n/m 9.21
Earnings yield 300,221.00% 11,368.55% (33.15%)
Free cash flow yield (2,869.14%) (2,331.48%) (25.50%)

Profitability

Metric CERO SCNI Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 453.76% 0.00% (56.36%)
Return on assets (2,352.32%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CERO SCNI Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 92.12% (159.83%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CERO SCNI Biotechnology median
Debt to equity (0.02) 0.02 0.00
Current ratio 0.05 1.56 4.72
Net debt to EBITDA 0.10 0.25 0.96

Dividend

Metric CERO SCNI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CERO SCNI Biotechnology median
Market cap 140.00k 640.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack